Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Relative Bioavailability of XmAb®5871 Administered Either Intravenously or Subcutaneously

NCT02867098 is registered in ClinicalTrials.gov with Xencor, Inc. as lead sponsor.

NCT NCT02867098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Relative Bioavailability of XmAb®5871 Administered Either Intravenously or Subcutaneously
Lead sponsor
Xencor, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2016
Completion date
October 21, 2016
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers